The human cytomegalovirus (HCMV) UL112-113 gene is implicated in lytic viral replication. The UL112-113 proteins p34, p43, p50 and p84 are expressed via alternative splicing. However, the mechanism for the generation of three additional virus-associated proteins (p20, p26 and p28), which share the UL112 reading frame, remains unknown. Bioinformatic analyses indicated that p34, p43, p50 and p84 contain potential PEST-like degradation motifs. In this study, inhibitors of calpains, lysosomes and proteasomes reduced p20, p26 and p28 levels in virus-infected cells, suggesting the involvement of proteolytic modification. Moreover, maitotoxin, which increases intracellular calcium levels and activates calpain activity, induced the intracellular proteolysis of p34 into p20, p26 and p28 and the cleavage of p43, p50 and p84 into p38 and a novel protein, p34c. Proteolytic assays further indicated that p34, p43, p50 and p84 were substrates of calpain-1 and calpain-2 and that they generated proteolytic products that corresponded to those detected during the HCMV infectious period. Furthermore, substitution mutations in the putative calpain cleavage sites of p34 reduced accumulation of proteolytic products. The knockdown of endogenous calpain-1 and calpain-2 by RNA interference reduced accumulation of p20, p26 and p28 and concurrently increased levels of nascent p43, p50 and p84 during the infectious cycle. Intriguingly, calpain depletion enhanced viral genome synthesis. Moreover, HCMV-permissive cells that stably expressed p20, p26 or p28 exhibited reduced viral genome synthesis and mature virus production. Our findings suggest that cognate UL112-113 proteins derived from calpaincatalysed proteolysis are involved in the HCMV replication process.
INTRODUCTION
Human cytomegalovirus (HCMV), a member of the Herpesviridae family, is a ubiquitous virus in the human population. HCMV infection remains asymptomatic with a lifelong latency in most healthy individuals. However, the virus is associated with two severe clinical outcomes: neurological defects in neonates and systemic infections in immunocompromised patients (Reddehase, 2013) . The HCMV genome contains~240 kb of dsDNA (NC_006273.2) and produces at least 153 proteins (Mocarski et al., 2013) . Understanding the productive cycle is important for management of HCMV infection. latent virus and the full replicative cycle (McDowell et al., 2013; Rossetto et al., 2011) . UL112-113 has been vaguely described as a pre-replication complex.
To elucidate the function of UL112-113, we aimed to characterize its coding content. Previously, we showed that the UL112-113 region produces eight cognate proteins, p20, p26, p28, p34, p38, p43, p50 and p84 (Wang et al., 2009) . The p34 protein is translated from the un-spliced transcript, whereas alternative splicing yields p43, p50 and p84. The p34, p43, p50 and p84 proteins share the exon 1 sequence, which encodes 252 N-terminal amino acids. The p43, p50 and p84 proteins contain amino acids from exon 2, whereas their C-terminal sequences are each derived from unique exons (Wang et al., 2009; Wright & Spector, 1989) . The additional proteins p20, p26, p28 and p38 also contain UL112 exon 1. Moreover, p20, p26 and p28 are selectively packaged into viral particles (Wang et al., 2009) . Because the N-termini of UL112-113 proteins likely bind to DNA, are required for self-interaction and mediate the recruitment of replication complexes (Kim & Ahn, 2010; Park et al., 2006) , we reasoned that the proteolytic processing of UL112-113 proteins merited further investigation.
Bioinformatic analyses indicated that UL112-113 proteins contain two likely PEST motifs (ePESTfind scores .10; PEST scores greater than five are considered significant) and disordered C-termini (Rechsteiner, 1990; Rechsteiner & Rogers, 1996) . Therefore, we hypothesized that p20, p26 and p28 originate from the proteolytic modification of p34, p43, p50 and p84. The ubiquitin-proteasome system, the lysosome and the caspase and calpain pathways mediate the proteolysis of PEST-containing proteins (Belizario et al., 2008; Rechsteiner & Rogers, 1996) .
During the HCMV infectious cycle, Ca 2+ influx occurs upon HCMV attachment, followed by sustained increases in intracellular Ca 2+ levels . During the IE phase of infection, intracellular Ca 2+ is stored in the endoplasmic reticulum/mitochondria and is slowly discharged into the cytosol during the early and late phases of infection (Albrecht et al., 1990; Nokta et al., 1987) . Therefore, Ca 2+ channel blockers, such as nifedipine and verapamil, inhibit HCMV production Nokta et al., 1987) . Thapsigargin and clotrimazole, which inhibit ER calcium ATPase, similarly reduce HCMV production (Isler et al., 2005) . These studies indicate the critical role of Ca 2+ in HCMV production; however, the mechanisms underlying the effects of Ca 2+ elevation are not well understood.
Calpains are a class of cysteine-proteases that catalyse the Ca 2+ -dependent proteolysis of substrates in a limited and defined manner (Campbell & Davies, 2012; Sorimachi et al., 2011) . The proteolytically modified products perform novel regulatory functions implicated in many biological pathways (Goll et al., 2003) . The human genome contains 14 genes that encode calpain-like proteins. Calpain-1 and calpain-2 (also named m-calpain and m-calpain, respectively) are most abundant and are ubiquitously expressed in mammalian cells. Calpain-1 and calpain-2 form inactive heterodimers consisting of a catalytic subunit isoform and a common small regulatory subunit named calpastatin. Ca 2+ binding stimulates the proteolytic activity of calpains (Campbell & Davies, 2012) . In this study, we demonstrated that the virus-associated proteins p20, p26 and p28 generated by calpain-dependent proteolysis suppressed viral genome synthesis and production. To our knowledge, this study is the first to discover that the cellular calpain system regulates HCMV replication.
RESULTS
Protease inhibitors block the production of p20, p26 and p28 in vivo
To investigate the susceptibility of UL112-113 proteins to protease degradation, we analysed the proteolytic signals within the protein sequences. An analysis using the ePESTfind program revealed that the UL112-113 proteins contained one closely related PEST motif (Fig. S1a , available in the online Supplementary Material): p34, amino acids 244 to 256, score518.58; p43, p50 and p84, amino acids 244 to 258, score513.45. In addition, p84 exhibited the following PEST signals that may confer its instability: amino acids 407 to 433, score512.59; amino acids 433 to 448, score52.80 (Rechsteiner & Rogers, 1996) .
To determine the protein degradation pathways or proteases that respond to the potential PEST signals, we assessed the effects of proteasome, lysosomal protease and caspase inhibitors on the UL112-113 proteins (Fig. 1) . Clasto-lactacystin b-lactone is a specific inhibitor of proteasome and cathepsin A (Dick et al., 1997; Ostrowska et al., 1997) . E-64 is a calpain inhibitor with less specificity for cathepsins B, H and L (Barrett et al., 1982) . MG-132 exhibits strong inhibitory activity against the proteasome, calpain, cathepsin A and cathepsin B (Ostrowska et al., 1997; Tsubuki et al., 1996; Wilk & Figueiredo-Pereira, 1993) . HEL cells were infected with HCMV and treated with either the solvent control DMSO (denoted by D, lanes 2, 14 and 15) or the protease inhibitors. At 24 h postinfection (p.i.), no visible signs of toxicity were observed in the cells (data not shown). Then, the cell lysates were harvested and analysed by immunoblotting. As shown in Fig. 1 , the p20, p26 and p28 proteolytic products were marginally reduced in the cells treated with 10 or 20 mM clasto-lactacystin b-lactone (Fig. 1, lanes 3 and 4) . The levels of p20, p26 and p28 decreased as the E-64 concentration increased from 10 to 50 mM (Fig. 1 , lanes 5 and 6). However, these three products were significantly reduced after treatment with 10 and 20 mM MG-132 (Fig. 1 , lanes 7 and 8), whereas p50 and p84 were concurrently increased. We further tested the effects of lysosome/ endosome inhibitors on the UL112-113 proteins. Chloroquine, an inhibitor of lysosomal hydrolases (GonzalezNoriega et al., 1980) , at 100 and 200 mM prevented the production of p20, p26 and p28 (Fig. 1, lanes 9 and 10) .
Ca074Me, a specific inhibitor of cathepsin B, at concentrations as low as 1, 5, or 10 mM, nearly eliminated p20, p26 and p28 production (Fig. 1, lanes 11-13) . In contrast, caspase inhibitor I, a universal caspase inhibitor (Chandler et al., 1998) , at concentrations from 1 to 100 mM had no effect on the p20, p26 and p28 levels (Fig. 1, lanes 16-18) . Therefore, we ruled out the involvement of caspases in p34 proteolysis. Collectively, the inhibitory effects of MG-132, E-64, chloroquine and Ca074Me indicate that the proteolytic cleavages of p20, p26 and p28 are likely mediated by calpain, the proteasome or cathepsin B.
Calcium influx elicits proteolysis of the UL112-113 proteins
Maitotoxin was used to test whether calpain activation leads to the proteolysis of transiently expressed UL112-113 proteins. Maitotoxin is purified from the marine dinoflagellate Gambierdiscus toxicus (Legrand & Bagnis, 1984) and activates calpain by increasing cytoplasmic calcium levels via the activation of non-selective cation channels (Brereton et al., 2001) . As shown in the left panel of Fig. 2 , p34 was degraded to p20, p26 and p28 after 30 min treatment by maitotoxin. Proteolysis occurred in a dosedependent manner as the concentration of maitotoxin increased ( Fig. 2a ; 0, 10, 25 and 50 pM, lanes 1-4, respectively). Additionally, maitotoxin promoted the cleavage of p43, p50 and p84 into the major products p38 and p34c and the minor products p20, p26 and p28 (Fig. 2b , lanes 2, 4, 6 and 8). The p34c protein is a new finding in this study, whereas p38 was identified by proteomic analyses in our previous study (Wang et al., 2009) . Our results suggest that the maitotoxin-induced protease modulates the proteolysis of UL112-113 proteins.
Moreover, maitotoxin specifically activated calpain but neither caspase nor cathepsin B (Knoblach et al., 2004; Zhao et al., 1999) .
His-p34 is a substrate of calpain-1 and calpain-2
To investigate whether UL112-113 proteins are calpain substrates, in vitro proteolysis was performed using highly purified His-p34 (Fig. S2) as the substrate and cellular calpains, calpain-1 and calpain-2, as the proteases. After the cleavage reactions, the products were analysed by immunoblotting. Increases in calpain-1, namely 0, 0.004, 0.02, 0.1 and 0.5 units (Fig. 3a, lanes 1-5) , led to decreased His-p34 levels with concomitant increases in the three proteins with apparent molecular mass of 20.4, 20.9 and 29.5 kDa as detected by the anti-UL112 antibody. The presence of the 20.4 and 20.9 kDa products was confirmed by overexposure [ Fig. 3a(i) , lower panel]. To verify that these protein products were specifically cleaved by calpain-1, the calpain inhibitor E-64 was added to the reaction. Reactions were performed with 0.5 units calpain-1 either without E-64 [ Fig. 3a (ii), lane 1] or with increased concentrations of E-64 [ Fig. 3a (ii); 0.1, 1, 10 and 30 mM, lanes 2-5, respectively]. His-p34 was used as a control [ Fig. 3a (ii), lane 6]. The UL112-antibody immunoblotting revealed that the 20.4, 20.9 and 29.5 kDa products gradually disappeared with increased concentrations of E-64. Conclusively, these results indicate that His-p34 is a calpain-1 substrate.
We also investigated whether calpain-2 cleaves His-p34 under the same conditions performed with calpain-1. Increasing amounts of calpain-2 [ Fig. 3b , lanes 3 and 4, respectively; 10 and 50 mM E-64 (E), lanes 5 and 6, respectively; 10 and 20 mM MG-132 (M), lanes 7 and 8, respectively; 200 and 100 mM chloroquine (Cq), lanes 9 and 10, respectively; 10, 5 and 1 mM CA074ME (C), lanes 11-13, respectively; 1, 10 and 100 mM caspase inhibitor I (CAPS I), lanes 16-18, respectively. The immunoblots were probed with a polyclonal rabbit anti-UL112 antibody. The 100 kDa non-specific bands, which are marked by asterisks (*), were used as internal controls. The numbers to the left of the blot indicate the molecular mass in kDa. In summary, His-p34 might contain at least three cleavage sites for calpain-mediated proteolysis. Nevertheless, bacterially purified His-p34 and its cleavage products are different in size from the UL112-113 proteins expressed during the HCMV infectious cycle. We next performed bioinformatic analyses to predict the positions cleaved by calpain during HCMV infection, and a summary of the analyses is shown in Fig. S1 (b). The numbers above the probability peaks indicate the putative calpain cleavage residues, which were compiled from three programmes, LabCaS, CaMPDB and GPS-CCD. Critically, the migration positions of the protein products resolved via PAGE were taken into consideration. We deduced that Ser200, Leu231 and Arg243 of p34 and His269 and Ser323 of p43, p50 and p84 are the putative cleavage sites for the production of p20, p26, p28, p34c and p38. The theoretical molecular masses of the nascent proteins are shown in Fig. 3 (c). It is likely that Ser198 is the cleavage site for the 20.4 kDa product of His-p34. The involvement of the PEST motif in the calpain-mediated proteolysis of His-p34 is presented in Fig. 3(d) . Purified His-p34DPEST (Fig. 3e , lane 1), in which the PEST sequence from His-p34 is deleted, was resistant to calpain-1-and calpain-2-mediated cleavage (Fig. 3e , lanes 2 and 3), suggesting that the PEST motif facilitates calpain proteolysis.
Mutating the putative calpain cleavage sites blocks p34 proteolysis
To further confirm that eukaryotically produced p34 is a substrate of calpain-1 and calpain-2, we expressed p34 in transiently transfected HEK293T cells. The cell lysates were subjected to a calpain-1 or calpain-2 reaction and the products were analysed by immunoblotting. As shown in Fig. 4 (a), p34 was cleaved into p20, p26 and p28, which migrated close to the corresponding UL112-113 proteins.
To create p34 substitution mutants that are calpainresistant, we used the sequence determinants for calpainsubstrate cleavage as a guide (Tompa et al., 2004) . The favoured amino acids in the contiguous cleavage position were substituted with residues that are disfavoured for proteolysis and three programmes were used to compile the mutated sequences and to determine whether the cleavage sites were disrupted. Once the substitution mutations were selected, the corresponding primers were designed to perform site-directed mutagenesis of p34. Six substitution mutations for p34 were generated as shown in Fig. 4 (b): p34(S199I, S200D) for Ser200; p34(A201I, G202D) for Ala201; p34(L230F, L231I) for Leu231; p34(E242A), p34(R243A, R244A) and p34(P246L, P247I) for Arg243. Eukaryotic clones for each substitution mutant were transfected into HEK293T cells. Protein lysates were used for proteolytic assays and the products were analysed. As shown in Fig. 4(c) , the calpain-digested products were p20, p26 and p28 for the control p34. The protein p34(S199I, S200D) did not produce p20 by either calpain-1 or calpain-2 proteolysis, indicating that p20 was derived from the cleavage at Ser200. The digestion products from p34(A201, G202D) were unchanged compared with wildtype p34, suggesting that either Ala201 is not a calpain cleavage site or the mutation failed to block proteolysis. The protein p34(L230F, L231I) produced significantly reduced levels of p26 for both calpain-1 and calpain-2 proteolysis, indicating that p26 was derived from the cleavage at Leu231. The digestion products for p34(E242A) and p34(R243A, R244A) were unchanged. The calpain digestion products for p34(P246L, P247I) did not contain p28 but produced a protein with a higher molecular mass, consistent with the prediction that the cleavage site shifted to the C-terminus. Collectively, these results suggest that the putative calpain cleavage residues for p20, p26 and p28 are Ser200, Leu231 and Arg243, respectively.
Calpain-1 and calpain-2 mediate the proteolysis of p43, p50 and p84
To determine whether the proteolytic products of p43, p50 and p84 induced by maitotoxin resulted from calpain activation, the lysates from transfected cells that expressed p43, p50 or p84 were incubated with or without calpain-1 (Fig. 5a ) and calpain-2 (Fig. 5b) . The predominant p43, p50 and p84 cleavage products were p34c and p38; however, lower levels of p20, p26 and p28 were produced. These products corresponded to the UL112-113 proteins at 96 h p.i. Similar to the maitotoxin experiment, the novel p34c protein, which is presumably derived from the cleavage of p43, p50 and p84 at His269, appeared in the calpain reaction. The p34c protein likely lacks 15 amino acids unique to the C-terminus of p34. To determine whether the HCMV infectious cycle generates p34c, we duplicated the protein loading conditions for p34, p34c and the cell extracts from 96 h p.i. As shown in Fig. 5(c) , one immunoblot was probed with the anti-UL112 antibody, whereas the other immunoblot was probed with an anti-p34 antibody that recognizes the unique C-terminus of p34. We normalized the intensities using p34 from transfected cell extracts. The HCMV-infected cell extracts were at 53 % intensity compared with the p34-transfected lysates, presumably due to the presence of both p34 and p34c (Fig. 5c, left) , whereas the p34-specific protein was present at only 44 % intensity compared with the p34-transfected lysate (Fig. 5c, middle) . The differences between p34 and p34c in the infected lysates were statistically significant (P,0.05), suggesting that the infected cell extracts contained p34 and p34c, which migrated to the same position. At 96 h p.i., p34 and p34c represented 82 and 18 % of the total proteins, respectively. Fig. 5(d) shows that p38, which was generated from the putative cleavage site at Ser323, migrated to the proximity of p38 from the infected cell lysates. We created substitution mutants around His269 and Ser323 to inhibit the cleavages. Up to four amino acids were substituted for each cleavage site in the p43 template; however, no inhibition of proteolysis was detected from the mutations (data not shown).
The knockdown of calpain-1 and calpain-2 impedes the proteolysis of UL112-113 proteins
To delineate the impact of reducing both calpain-1 and calpain-2 on the viral production cycle, calpain-1 and calpain-2 were simultaneously knocked down in HEL cells using specific short hairpin RNAs (shRNAs). After a 3-day transduction, the efficiencies of calpain-1 and calpain-2 depletion were 85 and 78 %, respectively (Fig. 6a) . Following HCMV infection, the calpain-depleted HEL cells maintained knockdown efficiencies for calpain-1 (ranging from 84-95 %) and calpain-2 (89-95 %) during infectious cycles (Fig. 6b) . The production of viral proteins IE2p86, UL112-113, pUL44 and pUL99 was analysed (Fig. 6b) . Under calpain depletion, reduction of IE2p86 levels was observed up to 40 h p.i., however, no differences were detected at 48-72 h p.i. At 24 h p.i., the proteolytic profiles of the UL112-113 proteins were slightly different in regard to the levels of p20 and p43. From 32 h to the late phase of infection, the differences were visibly distinguishable compared with the respective control. Decreases in the proteolytic products of p20, p26, p28 and presumably p34c were detected during the early phase of infection at 40 h p.i. Concurrently, p43, p50 and p84 accumulated throughout the infection cycle. We also assessed the expression of one essential replication protein, pUL44, which was not affected under calpain depletion. The late-expressing tegument protein pUL99 accumulated under calpain depletion at 48 h p.i. However, no evidence indicates pUL99 to be a substrate of calpains. These findings implicate calpains in several stages of the replicative cycle.
To assess the long-term effects of reducing calpain-1 and calpain-2 expression on HCMV replication, we quantified the genome copies over the infectious course. Quantitative PCR analyses showed little increase in genome copy number at 24 h p.i. (1.02-fold). At 32 h p.i., genome synthesis was greater (1.37-fold) than that of control cells (Fig. 6c, (Fig. 6c, lower panel) , suggesting that calpain activities play roles in the late phase of egress.
The overexpression of p20, p26 or p28 suppresses HCMV genomic DNA synthesis and reduces virus production
To further delineate the functions of p20, p26 and p28, we constructed U-373 MG cells that stably expressed intact p20, p26 or p28 (Fig. 7a) . These cells were infected with HCMV and viral genome synthesis was measured using four stable cell lines for each protein. genome synthesis was suppressed in cells stably expressing p20, p26 and p28 (Fig. 7b) . The relative proportions of products gradually decreased during the infectious period down to 0.12-fold after 48 h of infection. The proportions of p20 and p26 were reduced to approximately half of those of the controls. The amounts of infectious particles released at 7 days p.i by the p20-, p26-and p28-expressing cells also markedly decreased (0.58-, 0.42-and 0.20-fold, respectively) (Fig. 7c) .
DISCUSSION
To reveal the potential roles of UL112-113 in HCMV replication, it is necessary to understand the coding proteins. Initially, we aimed to identify the proteases carrying out the proteolysis. Based on the results from protease inhibitor assays (Fig. 1) , we hypothesized that inhibition of calpains selectively reduces levels of p20, p26 and p28. This speculation was substantiated by the finding that increasing intracellular calcium levels by maitotoxin unveiled the generation of two novel products, p34c and p38, in addition to p20, p26 and p28 (Fig. 2) . Notably, p34c and p38 were the major products under intracellular calcium induction (Fig. 2) and in extracellular proteolytic reactions (Fig. 5) , suggesting that they were preferential cleavage sites for substrates p43, p50 and p84. In contrast, abundant p20, p26 and p28 were present throughout the infectious cycle, indicating that p34, p34c and p38 may undergo further proteolysis (Figs 4a and 6b) (Wang et al., 2009) . However, we were not able to detect the C-terminal substrates by probing with antibodies that specifically recognized C-termini, suggesting that they were unstable and readily degraded (p34 in Fig. 5c ; other proteins not shown).
In this study, we demonstrated that UL112-113 proteins are the substrates of calpain-1 and calpain-2. The production of similar amounts of UL112-113 processed proteins in the late phase in HCMV-infected cells depleted of calpain-1 and calpain-2 might be explained by the presence of other calpain-like proteins. Specifically, a proteomic analysis validates the presence of calpain-1, -2, -5 and calpain-7 in HCMV-infected cells (Weekes et al., 2014) . Surprisingly, we detected increases in HCMV genome synthesis and decreases of mature viral production in cells with calpain deficiency (Fig. 6c) . Among essential replication proteins, IE2p86 level decreased only at the early stage of infection, pUL44 showed no apparent change and the total UL112-113 proteins did not appear to alter, except for the profiles of the proteolytic proteins (Fig. 6b) . Taken together, calpains may be restriction factors for HCMV genome synthesis.
Previous studies have demonstrated that calpains play roles in the HCMV infectious cycle. At the onset of infection, calpain mediates the degradation of p21 cip , which modulates cell cycle progression to favour viral infection . Moreover, HCMV pUL3761-activated Ca 2+ -dependent protein kinase Ca (PKCa) is mediated by calpain-1 cleavage of PKCa, which is linked to the large vesicle formation required for producing mature viruses (Sharon-Friling & Shenk, 2014) . Consistent with our findings, knockdown of calpain-1 reduces virus production, suggesting that calpains are required for optimal virus production at the late phase of HCMV infection (SharonFriling & Shenk, 2014) .
UL112-113 employs alternative splicing and calpaindependent proteolytic modulation to create a set of nine proteins. The key finding that the products generated from the proteolysis of UL112-113 proteins reduced the efficiency of replication may represent a novel mechanism that underlies the prolonged growth cycle of HCMV. Many cellular and viral factors identified are associated with oriLyt sequence, including the UL112-113 proteins (Kagele et al., 2012) . We do not have a comprehensive understanding of the pre-replicative process of HCMV and the components of UL112-113 proteins involved. It is fundamental to investigate the DNA responsive sequences of UL112-113 proteins in both the oriLyt region and the HCMV genome. We are currently approaching this direction.
METHODS
Cells, viruses and inhibitors. Human embryonic lung cells (HEL299), human glioblastoma U-373 MG cells, HEK293T cells and the HCMV strain AD169 (ATCC VR-538) were obtained from the ATCC. Virus propagation and HEL cell cultures were performed as previously described (Wang et al., , 2004 . The following protease inhibitors were purchased from Calbiochem and dissolved in DMSO: MG-132, E-64, clasto-lactacystin b-lactone, chloroquine, CA074 methyl ester and caspase inhibitor I [Z-VAD(OMe)-FMK]. Maitotoxin was purchased from Wako Pure Chemical Industries. HEL cells were plated at a density of 1.5610 6 cells in 60 mm culture dishes the day before viral infection. HEL cells were infected with HCMV at an m.o.i. of 1 p.f.u. per cell for 8 h and treated with an inhibitor for an additional 16 h. The cells were harvested and lysed in RIPA buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1 % NP-40, 0.5 % sodium deoxycholate and 1 mM EDTA) containing protease inhibitor cocktail (Roche). The protein extracts were recovered from the supernatant after centrifugation at 20 000 g for 30 min at 4 uC.
Antibodies and immunoblot analysis. The rabbit polyclonal antibodies for HCMV UL112 (Wang et al., 2009) and IE2p86 (Huang et al., 2000) were described previously. An antibody against the C-terminal sequence of p34 was generated by immunizing rabbits with a synthetic oligopeptide (GESRPSSRHGAFRVDSC, 253 to 268 amino acids). Polyclonal antibodies for calpain-1 and calpain-2 were purchased from Cell Signalling Technology. Murine mAb against pUL44 and pUL99 was obtained from the RumbaughGoodwin Institute for Cancer Research. For immunoblotting, the extracts from infected, transduced or transfected cells were resolved via SDS-PAGE and were transferred onto PVDF membranes. Chemiluminescence was detected according to the manufacturer's protocol (Immobilon Western Chemiluminescent kit).
Proteolytic cleavage assay. Human erythrocyte calpain-1 and recombinant rat calpain-2 were purchased from Calbiochem. The specified amount of calpain was mixed with 25 ng bacterially purified His-p34 or cell lysates from transfected HEK293T cells in buffer containing 25 mM HEPES (pH 7.0), 100 mM NaCl, 3 mM DTT and 5 mM CaCl 2 . After incubation at 30 uC for 30 min, the reaction was terminated by adding 10 mM EDTA.
Bioinformatic tools. Bioinformatics-based computational analyses were employed to predict the protein structures. The programmes were as follows: to identify cleavage sites in calpain substrates, CaMPDB (http://calpain.org./) (duVerle et al., 2010 (duVerle et al., , 2011 , LabCaS (http://www. csbio.sjtu.edu.cn/bioinf/LabCaS/) (Fan et al., 2013) and GPS-CCD (http://ccd.biocuckoo.org/) ; and for PEST motifs, ePESTfind (http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind).
Mutagenesis and plasmid construction. To create substrate knockout mutations at the calpain cleavage sites, bioinformatic programmes were used to compile the predictions. Substitution mutations were introduced at p34(S199I, S200D), p34(A201I, G202D), p34(L230F, L231I), p34(E242A), p34(R243A, R244A) and p34(P246L, P247I); the eukaryotic expression construct pECEp34 was used as the template for mutagenesis. The resulting plasmids were designated pECEp34(S199I, S200D), pECEp34(A201I, G202D), pECEp34(L230F, L231I), pECEp34(E242A), pECEp34(R243A, R244A) and pECEp34(P246L, P247I). To express a single transcript for p84, pECEp84a was constructed via mutagenesis of pECEp84 by eliminating the splicing donor signal for the p43 and p50 transcripts. The primers are listed in Table S1 . Mutagenesis was performed according to the QuikChange II XL Site-Directed Mutagenesis protocol (Agilent Technologies).
Transfection. For protein production via transfection, 6610 5 HEK293T cells were plated in 60 mm culture dishes the day before transfection. Transfection was performed with 3 mg DNA per dish using Lipofectamine Plus and Lipofectamine (Life Technologies). After incubation for 48 h, the cells were harvested and lysed in RIPA buffer.
RNA interference. A lentivirus-based approach was used to knock down human calpain-1 and calpain-2 expression. A calpain-1-shRNA plasmid that expressed shRNA (TRCN0000003561), a calpain-2-shRNA plasmid that expressed shRNA (TRCN0000284853) and a control plasmid (pLKO_TRC025) were provided by the National RNAi Core Facility. To knock down endogenous calpain-1 and calpain-2 simultaneously, HEL cells were transduced with the pseudoviruses at an m.o.i. of 8 infectious units per cell for 24 h. The cells were selected in 2 mg puromycin ml 21 and further cultured for 3 days. HCMV was inoculated at an m.o.i. of 1 p.f.u. per cell. At 24, 32, 40, 48 and 72 h p.i., the transduced and infected cells were harvested for the immunoblot analyses. The control pseudoviruses (ctr) were used as a non-knockout control.
Quantitative PCR. U-373 MG cells that stably expressed p20, p26 or p28 were infected at an m.o.i. of 1 p.f.u. per cell and harvested at 8, 16, 24, 32, 40 and 48 h p.i. Genomic DNA was purified and quantitative PCR analyses were performed. The HCMV UL76-specific primers and TaqMan probes (Applied Biosystems) were as follows: forward, 59-CGTTCGGGCCGTTTCG-39; reverse, 59-GACGCCGTC-CCAGATAGTC-39; probe, FAM-59-ACTTGTGTACCGATTCTGTC-39-NFQ. Real-time PCR was performed for 40 cycles (15 s at 95 uC and 60 s at 60 uC), and two different dilutions (25 and 50 ng DNA) of each sample were assayed with three repeats. The amount of the HCMV genome was calculated by comparing the threshold cycle (Ct) value of each sample to a standard curve that was plotted from the amplification of DNA from the UL76 plasmid. The standard curve for the human chromosome was plotted from the amplification of endogenous RNase P (Applied Biosystems).
